It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback